Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Mid Cap | Pharmaceuticals & Drugs
1461.00
-0.55 (-0.04%) Cipla - Quaterly Results
Date: 24-07-2026
The company's total revenue for the quarter ended June 2026 saw a slight change in the total revenue, having registered a total revenue of Rs. 50776.80 millions.Net profit of the cmpany stood at Rs. 8621.60 millions for the quarter ended June 2026 a decline of -33.84% from Rs. 13031.30 millions in the same quarter last year.Operating Profit reported a sharp decline to 13286.90 millions from 18955.20 millions in the corresponding previous quarter.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 50776.80 | 50461.70 | 0.62 | 50776.80 | 50461.70 | 0.62 | 189799.50 | 190448.50 | -0.34 |
| Other Income | 2427.50 | 2710.70 | -10.45 | 2427.50 | 2710.70 | -10.45 | 11226.50 | 9847.20 | 14.01 |
| PBIDT | 13286.90 | 18955.20 | -29.90 | 13286.90 | 18955.20 | -29.90 | 55890.40 | 67631.60 | -17.36 |
| Interest | 56.80 | 58.80 | -3.40 | 56.80 | 58.80 | -3.40 | 193.00 | 151.10 | 27.73 |
| PBDT | 13230.10 | 18896.40 | -29.99 | 13230.10 | 18896.40 | -29.99 | 53253.70 | 70427.10 | -24.38 |
| Depreciation | 1693.90 | 1456.90 | 16.27 | 1693.90 | 1456.90 | 16.27 | 6894.30 | 5738.90 | 20.13 |
| PBT | 11536.20 | 17439.50 | -33.85 | 11536.20 | 17439.50 | -33.85 | 46359.40 | 64688.20 | -28.33 |
| TAX | 2914.60 | 4408.20 | -33.88 | 2914.60 | 4408.20 | -33.88 | 11207.60 | 13111.70 | -14.52 |
| Deferred Tax | -164.30 | -152.20 | 7.95 | -164.30 | -152.20 | 7.95 | 188.60 | -491.50 | -138.37 |
| PAT | 8621.60 | 13031.30 | -33.84 | 8621.60 | 13031.30 | -33.84 | 35151.80 | 51576.50 | -31.85 |
| Equity | 1615.70 | 1615.50 | 0.01 | 1615.70 | 1615.50 | 0.01 | 1615.60 | 1615.20 | 0.02 |
| PBIDTM(%) | 26.17 | 37.56 | -30.34 | 26.17 | 37.56 | -30.34 | 29.45 | 35.51 | -17.08 |